234 related articles for article (PubMed ID: 27404675)
1. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
Katz A; Maor E; Leor J; Klempfner R
Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675
[TBL] [Abstract][Full Text] [Related]
2. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
[TBL] [Abstract][Full Text] [Related]
4. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
[TBL] [Abstract][Full Text] [Related]
5. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
6. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
[TBL] [Abstract][Full Text] [Related]
7. Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
Nevzorov R; Porath A; Henkin Y; Kobal SL; Jotkowitz A; Novack V
Eur J Intern Med; 2012 Jun; 23(4):374-8. PubMed ID: 22560389
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
Gheorghiade M; Patel K; Filippatos G; Anker SD; van Veldhuisen DJ; Cleland JG; Metra M; Aban IB; Greene SJ; Adams KF; McMurray JJ; Ahmed A
Eur J Heart Fail; 2013 May; 15(5):551-9. PubMed ID: 23355060
[TBL] [Abstract][Full Text] [Related]
9. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
[TBL] [Abstract][Full Text] [Related]
11. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
[TBL] [Abstract][Full Text] [Related]
12. Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
Lam PH; Bhyan P; Arundel C; Dooley DJ; Sheriff HM; Mohammed SF; Fonarow GC; Morgan CJ; Aronow WS; Allman RM; Waagstein F; Ahmed A
Clin Cardiol; 2018 Mar; 41(3):406-412. PubMed ID: 29569405
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.
Bølling R; Scheller NM; Køber L; Poulsen HE; Gislason GH; Torp-Pedersen C
Eur J Heart Fail; 2014 Jun; 16(6):678-84. PubMed ID: 24706485
[TBL] [Abstract][Full Text] [Related]
14. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
16. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
Ahmed A; Pitt B; Rahimtoola SH; Waagstein F; White M; Love TE; Braunwald E
Int J Cardiol; 2008 Jan; 123(2):138-46. PubMed ID: 17382417
[TBL] [Abstract][Full Text] [Related]
17. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
[TBL] [Abstract][Full Text] [Related]
19. Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry.
Yazdi M; Shafie D; Givi M; Garakyaraghi M; Sarrafzadegan N; Yadegarfar G
ARYA Atheroscler; 2022 May; 18(3):1-10. PubMed ID: 36815953
[TBL] [Abstract][Full Text] [Related]
20. Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy.
Cho MS; Kim MS; Lee SE; Choi HI; Lee JB; Cho HJ; Lee HY; Choi JO; Jeon ES; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Ahn Y; Kim KH; Park HY; Cho MC; Oh BH; Kim JJ
Can J Cardiol; 2018 Sep; 34(9):1145-1152. PubMed ID: 30170669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
